|
?:authorAffiliation
|
-
[\'Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.\', \'Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.\', \'Department of Population and Quantitative Health Sciences, Case Comprehensive Cancer Center, Cleveland, OH, USA.\', \'Division of Solid Tumor Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.\', \'Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Center for Outcomes Research and Evaluation, New Haven, CT, USA.\', \'Vascular Biology Center, Augusta University, August, GA, USA.\', \'Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.\', \'Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'The Helen B. Taussig Heart Center, The Johns Hopkins Hospital and Johns Hopkins University, Baltimore, MD, USA.\', \'Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. avirup.guha@uhhospitals.org.\', \'Harrington Heart and Vascular Institute, UH Cleveland Medical Center, Cleveland, OH, USA. avirup.guha@uhhospitals.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}